Advertisement

Topics

Schering-Plough Corp. Company Profile

05:00 EDT 20th October 2017 | BioPortfolio

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer health care products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.


News Articles [42 Associated News Articles listed on BioPortfolio]

Merck & Co.: Merging With Schering-Plough and Future Plans

In this episode of PharmaTelevision News Review, Fintan Walton talks with Pamela Demain, Executive Director, Corporate Licensing at Merck & Co. Filmed at Bio-Europe Spring 2010 in Barcelona, Spain, th...

Former Schering-Plough CEO Says This is the 'Worst Solution' to the Drug Pricing Dilemma

  Life Sciences Jobs   ...

Researchers Get Atomic View of FPT Inhibitors in Action

Researchers at Schering-Plough Research Institute report what they say is the first atomic view showing how FPT inhibitors work...

PTV News: Nov 5, 2009

Top stories on November 5th, 2009: Merck complete Schering-Plough merger Novartis buys Chinese vaccine maker BioPad’s Joe Mosala Molete on South African biotech Pfizer on partnering: Doug Giordan...

Bayer Schering Pharma: Michael Yeomans on Growth in Pharma and New Deals

In this episode of PharmaTelevision News Review, Fintan Walton talks with Michael Yeomans, VP Business Development & Licensing at Bayer Schering Pharma*. Filmed at BioChicago 2010 in Chicago, USA, the...

The New Merck

In recent years, Merck & Co.'s corporate strategy has included a significant amount of licensing and partnering in order to externalise their pipeline and ensure that the company gets access to the be...

Caret Pharma To Acquire Fiber Choice®

BOCA RATON, Fla., Aug. 21, 2017 /PRNewswire/ -- Caret Pharma, a subsidiary of Caret Group, today announced it has entered into an agreement with Moberg Pharma AB to acquire the assets of Fiber Ch...

Helix BioPharma Corp. Director Resigns

TORONTO, ONTARIO -- (Marketwired) -- 07/17/17 -- Helix BioPharma Corp. (TSX: HBP)(FRANKFURT: HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the...

PubMed Articles [3 Associated PubMed Articles listed on BioPortfolio]

Increased static and decreased capacity oxidation-reduction potentials in plasma are predictive of metabolic syndrome.

Electric conductivity in plasma is the balance between oxidized and reduced molecules (static Oxidation-Reduction Potential, sORP) and the amount of readily oxidizable molecules (capacity ORP, cORP). ...

Variations in Oxidative Stress Levels in 3 Days Follow-up in Ultramarathon Mountain Race Athletes.

Spanidis, Y, Stagos, D, Orfanou, M, Goutzourelas, N, Bar-or, D, Spandidos, D, and Kouretas, D. Variations in oxidative stress levels in 3 days follow-up in ultramarathon mountain race athletes. J Stre...

Nutrient loads from agricultural and forested areas in Finland from 1981 up to 2010-can the efficiency of undertaken water protection measures seen?

Long-term data from a network of intensively monitored research catchments in Finland was analysed. We studied temporal (1981-2010) and spatial variability in nitrogen (N) and phosphorus (P), from 198...

Clinical Trials [11 Associated Clinical Trials listed on BioPortfolio]

Clinical Trial Of The Effectiveness Of The Product Cloratadd D (Loratadine + Pseudoephedrine Sulfate) Produced By The Laboratory EMS S/A, Compared To The Drug Claritin D Produced By Schering-Plough S/A, In Patients With Allergic Rhinitis

The primary objective of this study is to evaluate the clinical efficacy of the drug Cloratadd D ® (loratadine + pseudoephedrine sulfate - EMS S/A) compared to the drug Claritin D ® (lor...

Bioequivalence Study on Loratadine Orally Disintegrating Tablets 10 mg Under Fasting Conditions

To compare the single-dose oral bioavailability of loratadine 10 mg orally disintegrating tablets of Ohm Laboratories (a subsidiary of Ranbaxy Pharmaceuticals Inc., USA) with Claritin® Re...

Peg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCT

Aim: to observe the graft versus tumor effect of Pegylated Interferonα-2b in patients with hematological malignancies relapsed after allogeneic hematopoietic stem cell transplantation (al...

Acotral® Versus Zetia® Ezetimibe Bioequivalance Study.

Bioequivalence study comparing test Acotral® ezetimibe 10 mg tablet manufactured by Laboratorios Phoenix, with a reference comparator Zetia® ezetimibe 10 mg tablet of Merck/Schering-Plou...

Remicade Infusion Management Program (Study P04466)

Schering Canada plans to collect data on about 3000 to 5000 infliximab infusions per year, starting in the third quarter of 2005. It is expected that about 12 sites from the Remicade Infu...

Companies [77 Associated Companies listed on BioPortfolio]

Schering-Plough Corp.

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies th...

Intervet/Schering-Plough Animal Health

Intervet/Schering-Plough Animal Health, based in Boxmeer, the Netherlands, is focused on the research, development, manufacturing and marketing of animal health products. The company offers customers ...

Schering-Plough

Schering-Plough is committed to earning the trust of doctors, patients and customers every day. Our colleagues worldwide believe that trust is not easily granted, and that is the reason we focus each ...

Schering-Plough Corporation

Schering-Plough HealthCare Products, Inc.

More Information about "Schering-Plough Corp." on BioPortfolio

We have published hundreds of Schering-Plough Corp. news stories on BioPortfolio along with dozens of Schering-Plough Corp. Clinical Trials and PubMed Articles about Schering-Plough Corp. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Schering-Plough Corp. Companies in our database. You can also find out about relevant Schering-Plough Corp. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record